30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

ORTHOVITA raised $1MM in equity through an agreement it signed with JAPAN MEDICAL DYNAMIC MARKETING (MDM) for its VITOSS™ Synthetic Cancellous Bone Void Filler. The companies will work to obtain product approvals in Japan for the VITOSS product, after which MDM gains the right to market, sell and distribute VITOSS for 10 years. Orthovita also generated gross proceeds of ~ $3MM, through private equity financing that entailed the sale of 740,000 shares of common stock. Capital gained from this and previous financing will be used to further commercialize VITOSS and CORTOSS™ bone void fillers. (Orthovita, Inc., 4/25/01 and 4/30/01)